CERO THERAPEUTICS HOLDINGS, INC. cotiza a 0.01 USD y tiene una capitalización bursátil de $501417. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
CERo Therapeutics Holdings, Inc., an immunotherapy company, engages in the development of engineered T cell therapeutics for the treatment of cancer. The company's lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company w…
| Periodo | 2025-11 | 2025-08 | 2025-05 |
|---|---|---|---|
| Real | $-9.10 | $-61.71 | $-31.80 |
| Estimado | $-4.35 | $-6.21 | $-119.20 |
| Sorpresa | -109.2% | -893.7% | +73.3% |
| Métrica | CERO | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -547.1% | -32.0% | -515.1% |
| Current Ratio | 0.30 | 2.84 | -2.54 |
| Debt / Equity | — | 0.28 | — |